NEW YORK, (GenomeWeb News) – Invitrogen and Luminex jointly announced today that they have extended and expanded a licensing agreement for Luminex’s multiplex technology and systems.
 
The new license extends the lifetime of the license and expands Invitrogen’s rights to include Luminex’s next-generation multiplex detection platforms. The firms did not disclose the length of or terms of the agreement.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.